Fujifilm Avigan Found to Have Inconclusive Efficacy For COVID-19 Treatment


While early testing of Fujifilm’s antiviral drug Avigan looked promising for treating COVID-19 we haven’t heard much about the drug since October. Now that proper clinical testing is concluding Avigan is being put on hold for the treatment of COVID-19 in Japan until further clinical evidence of its efficacy shows otherwise acording to reuters. This is an unfortunate setback, but Fujiflm is helping to fight COVID-19 in multiple other ways including assisting in the production of vaccines.

 Other Avigan/COVID-19/Hydro Ag +/Fujifilm Biomedical Coverage ( 123456789, 1011121314151617181920212223242526272829303132, 33)

Please don’t forget to follow us on FacebookTwitterInstagramYouTube

Plus our owners’ groups
Fujifilm GFX Owners Group
Fujifilm X-H Owners Group
Fujifilm X-T Owners Group
Fujifilm X-S Owners Group
Fujifilm X-Pro Owners Group
Fujifilm X-E Owners Group
Fujifilm X-A Owners Group
Fujifilm X100 Owners Group

This entry was posted in Press releases and tagged , , , , , , . Bookmark the permalink. Trackbacks are closed, but you can post a comment.
  • FCC disclosure statement: this post may contain affiliate links or promotions that do not cost readers anything but help keep this website alive. Thanks for your support!